Home/Zyneyro/Kenneth Lindegaard Madsen
KL

Kenneth Lindegaard Madsen

Chief Development Officer & Co-Founder

Zyneyro

Zyneyro Pipeline

DrugIndicationPhase
ZYNPNNeuropathic PainPre-clinical